127 related articles for article (PubMed ID: 11237703)
1. The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287.
Youn BS; Yu KY; Alkhatib G; Kwon BS
Biochem Biophys Res Commun; 2001 Mar; 281(3):627-33. PubMed ID: 11237703
[TBL] [Abstract][Full Text] [Related]
2. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
3. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
4. Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope.
Staudinger R; Wang X; Bandrés JC
Biochem Biophys Res Commun; 2001 Aug; 286(1):41-7. PubMed ID: 11485305
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
Bondue A; Jao SC; Blanpain C; Parmentier M; LiWang PJ
Biochemistry; 2002 Nov; 41(46):13548-55. PubMed ID: 12427015
[TBL] [Abstract][Full Text] [Related]
6. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
7. The molecular cloning and functional expression of the dog CCR5.
Mosley M; Pullen S; Botham A; Gray A; Napier C; Mansfield R; Holbrook M
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):415-20. PubMed ID: 16806494
[TBL] [Abstract][Full Text] [Related]
8. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1alpha-binding activity.
Meta A; Torigoe N; Ito Y; Arakaki R; Nakashima H; Sugimura K
Mol Immunol; 1999 Dec; 36(18):1249-54. PubMed ID: 10684964
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and radioligand binding characterization of the chemokine receptor CCR5 from rhesus macaque and human.
Napier C; Sale H; Mosley M; Rickett G; Dorr P; Mansfield R; Holbrook M
Biochem Pharmacol; 2005 Dec; 71(1-2):163-72. PubMed ID: 16298345
[TBL] [Abstract][Full Text] [Related]
11. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
12. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.
McCornack MA; Boren DM; LiWang PJ
Biochemistry; 2004 Aug; 43(31):10090-101. PubMed ID: 15287737
[TBL] [Abstract][Full Text] [Related]
15. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
16. Antiviral chemokines: intracellular life of recombinant C-C chemokine RANTES.
Owais M; Arya SK
J Hum Virol; 1999; 2(5):270-82. PubMed ID: 10551733
[TBL] [Abstract][Full Text] [Related]
17. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
18. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
[TBL] [Abstract][Full Text] [Related]
19. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
